Detailed information for compound 231464

Basic information

Technical information
  • TDR Targets ID: 231464
  • Name: 1-cyclopropyl-8-[(3S)-3-(cyclopropylamino)pyr rolidin-1-yl]-7-fluoro-9-methyl-4-oxoquinoliz ine-3-carboxylic acid
  • MW: 385.432 | Formula: C21H24FN3O3
  • H donors: 2 H acceptors: 3 LogP: -0.31 Rotable bonds: 5
    Rule of 5 violations (Lipinski): 1
  • SMILES: Fc1cn2c(c(c1N1CC[C@@H](C1)NC1CC1)C)c(cc(c2=O)C(=O)O)C1CC1
  • InChi: 1S/C21H24FN3O3/c1-11-18-15(12-2-3-12)8-16(21(27)28)20(26)25(18)10-17(22)19(11)24-7-6-14(9-24)23-13-4-5-13/h8,10,12-14,23H,2-7,9H2,1H3,(H,27,28)/t14-/m0/s1
  • InChiKey: YKHKYIPHWVOAPA-AWEZNQCLSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 1-cyclopropyl-8-[(3S)-3-(cyclopropylamino)pyrrolidin-1-yl]-7-fluoro-9-methyl-4-oxo-quinolizine-3-carboxylic acid
  • 1-cyclopropyl-8-[(3S)-3-(cyclopropylamino)-1-pyrrolidinyl]-7-fluoro-9-methyl-4-oxo-3-quinolizinecarboxylic acid
  • 1-cyclopropyl-8-[(3S)-3-(cyclopropylamino)pyrrolidino]-7-fluoro-4-keto-9-methyl-quinolizine-3-carboxylic acid
  • 1-cyclopropyl-8-[(3S)-3-(cyclopropylamino)pyrrolidin-1-yl]-7-fluoro-4-keto-9-methyl-quinolizine-3-carboxylic acid
  • 1-Cyclopropyl-8-((S)-3-cyclopropylamino-pyrrolidin-1-yl)-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid
  • AIDS-094566
  • AIDS094566

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis carboxylesterase 5A 0.0141 0.6817 0.5
Echinococcus multilocularis acetylcholinesterase 0.0141 0.6817 0.5
Echinococcus granulosus acetylcholinesterase 0.0141 0.6817 0.5
Trichomonas vaginalis xanthine dehydrogenase, putative 0.019 1 0.5
Brugia malayi Carboxylesterase family protein 0.0141 0.6817 0.5
Loa Loa (eye worm) carboxylesterase 0.0141 0.6817 0.5
Mycobacterium ulcerans carbon monoxyde dehydrogenase medium chain CoxM 0.0064 0.1813 0.3111
Mycobacterium ulcerans aerobic-type carbon monoxide dehydrogenase subunit CoxM_2 0.0064 0.1813 0.3111
Echinococcus granulosus carboxylesterase 5A 0.0141 0.6817 0.5
Echinococcus granulosus acetylcholinesterase 0.0141 0.6817 0.5
Mycobacterium ulcerans carbon monoxyde dehydrogenase large chain CoxL 0.0056 0.1304 0.2238
Mycobacterium ulcerans aerobic-type carbon monoxide dehydrogenase subunit CoxL_2 0.0089 0.3468 0.5951
Loa Loa (eye worm) hypothetical protein 0.0141 0.6817 0.5
Mycobacterium tuberculosis Probable carbon monoxyde dehydrogenase (large chain) 0.0089 0.3468 1
Echinococcus multilocularis acetylcholinesterase 0.0141 0.6817 0.5
Loa Loa (eye worm) acetylcholinesterase 1 0.0141 0.6817 0.5
Trichomonas vaginalis aldehyde oxidase, putative 0.019 1 0.5
Mycobacterium ulcerans carbon monoxyde dehydrogenase large chain CoxL 0.0089 0.3468 0.5951
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.0141 0.6817 0.5
Brugia malayi Carboxylesterase family protein 0.0141 0.6817 0.5
Mycobacterium ulcerans carbon monoxide dehydrogenase 0.0126 0.5827 1
Loa Loa (eye worm) hypothetical protein 0.0141 0.6817 0.5
Mycobacterium tuberculosis Probable carbon monoxyde dehydrogenase (medium chain) 0.0064 0.1813 0.5229

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) = 3.6 mg kg-1 In vivo efficacy against S. aureus NCTC 10649M in mouse ChEMBL. 10514290
ED50 (functional) = 5 mg kg-1 In vivo efficacy against E. coli JUHL in mouse protection test after subcutaneous administration ChEMBL. 10514290
ED50 (functional) = 5 mg kg-1 In vivo efficacy against E. coli JUHL in mouse protection test after subcutaneous administration ChEMBL. 10514290
ED50 (functional) > 8 mg kg-1 In vivo efficacy against S. pneumoniae ATCC 6303 in mouse protection test after s.c. administration. ChEMBL. 10514290
ED50 (functional) = 16.5 mg kg-1 In vivo efficacy against E. coli JUHL in mouse protection test after p.o. administration. ChEMBL. 10514290
ED50 (functional) = 16.5 mg kg-1 In vivo efficacy against E. coli JUHL in mouse protection test after p.o. administration. ChEMBL. 10514290
ED50 (functional) = 23.1 mg kg-1 In vivo efficacy of the compound against S. pneumoniae ATCC 6303 in mouse protection test after administration by oral gavage ChEMBL. 10514290
ED50 (functional) = 23.1 mg kg-1 In vivo efficacy of the compound against S. pneumoniae ATCC 6303 in mouse protection test after administration by oral gavage ChEMBL. 10514290
ED50 (functional) = 25 mg kg-1 In vivo efficacy against S. aureus NCTC 10649M in mouse protection test after p.o. administration. ChEMBL. 10514290
ED50 (functional) > 32 mg kg-1 In vivo efficacy against P. aeruginosa 5007 in mouse protection test after subcutaneous administration ChEMBL. 10514290
ED50 (functional) > 50 mg kg-1 In vivo efficacy of the compound against P. aeruginosa 5007 in mouse protection test after subcutaneous administration by oral gavage ChEMBL. 10514290
ED50 (functional) > 50 mg kg-1 In vivo efficacy of the compound against P. aeruginosa 5007 in mouse protection test after subcutaneous administration by oral gavage ChEMBL. 10514290
MIC (functional) = 0.02 ug ml-1 In vitro antibacterial activity against gram-positive S. aureus NCTC 10649M ChEMBL. 10514290
MIC (functional) = 0.05 ug ml-1 In vitro antibacterial activity against gram positive S. pyogenes 930 ChEMBL. 10514290
MIC (functional) = 0.2 ug ml-1 In vitro antibacterial activity against gram-positive E. faecium ATCC 8043 ChEMBL. 10514290
MIC (functional) = 0.2 ug ml-1 In vitro antibacterial activity of the compound against gram negitive E. coli KNK 437 ChEMBL. 10514290
MIC (functional) = 0.2 ug ml-1 In vitro antibacterial activity of the compound against gram negitive E. coli KNK 437 ChEMBL. 10514290
MIC (functional) = 0.39 ug ml-1 In vitro antibacterial activity against gram-positive S. aureus 1775 ChEMBL. 10514290
MIC (functional) = 0.39 ug ml-1 In vitro antibacterial activity against gram negitive P. cepacia 2961 ChEMBL. 10514290
MIC (functional) = 0.39 ug ml-1 In vitro antibacterial activity against Gram-negative P. aeruginosa 5007 ChEMBL. 10514290
MIC (functional) = 12.5 ug ml-1 In vitro antibacterial activity against gram negitive P. aeruginosa DPHP 5263 ChEMBL. 10514290

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.